The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
April 18th 2025
Recently published research projected that 103,000 future cases of radiation-induced cancer would result from 93 million computed tomography (CT) exams performed in the United States in 2023.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
3D display creates stereoscopic images without glasses
November 1st 2006Siemens Medical Solutions will spotlight a new kind of medical display at the upcoming RSNA meeting, one that creates volumetric images that appear to hang in space beyond the flat screen of the monitor. Unlike similar systems that have popped up in the past, however, this display will not require the user to wear glasses.
Incidental findings raise costs of CT colonography
October 27th 2006Virtual colonoscopy finds anomalies outside the colon that require additional tests though they often present no risk to patients. These tests unnecessarily raise the overall cost of healthcare, making CT colonography more expensive than the traditional procedure, according to a study conducted by Dr. Richard S. Bloomfeld, an assistant professor of medicine at Wake Forest University Baptist Medical Center.
Philips gets FDA OK to market advanced gamma camera
October 20th 2006Philips Medical Systems gained 510(k) clearance in August to market a nuclear medicine camera that promises to overshadow the company’s high-performance Forte gamma camera. Philips declined to be interviewed about the new system, but the FDA document provides a detailed description.
Terrorist threat intensifies nuclear medicine’s “image” problem
October 9th 2006It should come as no shock that the word “nuclear” conjures negative reactions. This is why nuclear magnetic resonance imaging was abridged decades ago and may be why the Society of Nuclear Medicine lately prefers its acronym and a slogan steeped in molecular imaging.
GE seeks industry support for CT injector standard
October 6th 2006Most CT equipment forces technologists to turn into contortionists when techs administer CT contrast. With one hand on the scanner console and the other on the power injector key pad, the tech attempts to trigger the scan and injection simultaneously. Most of the time it works, but the process could be a lot easier and more productive.
The multimodality revolution offers business opportunities for vendors
September 18th 2006Hard though it is to believe, there is another issue facing outpatient imaging centers besides the Deficit Reduction Act, information technology, and turf wars. It’s the multimodality revolution, which encompasses plain film x-ray, ultrasound, and yes, even mammography.
In vitro test guides follow-up studies
September 14th 2006Underlying the appeal of personalized medicine is the link between in vitro and in vivo testing. The hope is that laboratory studies run on samples of body fluids will spot the earliest signs of disease, providing physicians with guidance on what to look for and where with imaging modalities.
The future of total service ranks a ‘high five’
September 1st 2006When discussing the importance of understanding your competition, we used a tool known as the High 5. The High 5 provides a company with the best approach to servicing customers. By knowing the five key factors a customer would use to select between competitors, and providing the best response to each, a company puts itself in the win position.
Philips focuses on computing power to pave way for advances
August 28th 2006Advances in computing power will reshape medical imaging, allowing the merger of diagnostic and therapeutic methods, according to Diego Olego, chief technology officer for Philips Medical Systems. The result will be expanded diagnostic applications and increased precision in targeting pathology for therapy.
Nuc med society modifies name, emphasizes molecular imaging
August 28th 2006The Society of Nuclear Medicine has shed its full name in favor of its acronym and a new tagline: “SNM: Advancing Molecular Imaging and Therapy.” The modification comes amid rapid changes in technology, therapy, and imaging. Diagnostic Imaging asked SNM president Dr. Martin Sandler to talk about the transformation.